Clinuvel
Stock
Stock
ISIN: AU000000CUV3
Ticker: CUV
AU000000CUV3
CUV
Price
Price
CHART BY
Historical dividends and forecast
Clinuvel has so far distributed $0.0357 in 2026. The next dividend will be paid on 18.09.2027
$0.0267
CHART BY
Frequently asked questions
What is Clinuvel's market capitalization?
The market capitalization of Clinuvel is 301.31M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Clinuvel's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Clinuvel is 13.00. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the free float of Clinuvel's shares?
The free float of Clinuvel is 42.21M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- 301.31M
- Free Float
- 42.21M
- P/E ratio (TTM)
- 13.00
Pricing
- 1D span
- $5.793$5.89
- 52W span
- $5.521$8.639
Information
Clinuvel Pharmaceuticals Ltd. operates as a biopharmaceutical company. The firm engages in the development of SCENESSE, its proprietary photoprotective drug. It also offers drugs for the treatment of various skin disorders. The company was founded by Robert Thomas Dorr on December 14, 1999 and is headquartered in Melbourne, Australia.
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- AU000000CUV3
- Primary Ticker
- CUV
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet